Healthcare >> CEO Interviews >> March 11, 2016
Gerald E. Commissiong is President, CEO, Co-Founder and a member of the board of directors of Amarantus BioScience Holdings, Inc. Mr. Commissiong has been responsible for leading the company's strategic transactions, licensing, research collaborations, mergers and acquisitions, and fundraising. He has raised over $40 million to acquire and develop assets to build robust therapeutics and diagnostics pipelines across neurology, regenerative medicine and orphan diseases, with a particular focus on Parkinson’s disease. Prior to becoming CEO in October 2011, Mr. Commissiong was the Chief Operating Officer. Prior to co-founding Amarantus with his father, Dr. John Commissiong, Mr. Commissiong played professional football for the Calgary Stampeders of the Canadian Football League. Mr. Commissiong received a B.S. in management science and engineering with a focus on financial decisions from Stanford University. Profile
Mr. Commissiong: The history is
